Caldwell Trust’s AstraZeneca AZN Stock Holding History

Caldwell Trust’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.31M	Buy	6,618 +1,108	+20%	+$214K	0.12%	142
2025 Q4	$1.01M	Buy	5,510 +5,336	+3,067%	+$936K	0.09%	164
2025 Q3	$26.6K	Hold	174	–	–	﹤0.01%	541
2025 Q2	$24.2K	Hold	174	–	–	﹤0.01%	543
2025 Q1	$25.6K	Buy	174 +133	+324%	+$19.2K	﹤0.01%	531
2024 Q4	$5.31K	Hold	41	–	–	﹤0.01%	649
2024 Q3	$6.31K	Buy	+41	New	+$6.62K	﹤0.01%	641
2024 Q2	–	Sell	-143	Closed	-$19.3K	–	693
2024 Q1	$19.3K	Sell	143 -42	-23%	-$5.56K	﹤0.01%	556
2023 Q4	$24.9K	Buy	185 +42	+29%	+$5.46K	﹤0.01%	522
2023 Q3	$19.3K	Hold	143	–	–	﹤0.01%	547
2023 Q2	$20.4K	Hold	143	–	–	﹤0.01%	552
2023 Q1	$19.8K	Hold	143	–	–	﹤0.01%	552
2022 Q4	$19.3K	Buy	+143	New	+$17.9K	﹤0.01%	543
2021 Q3	–	Sell	-24	Closed	-$2.81K	–	734
2021 Q2	$2.81K	Hold	24	–	–	﹤0.01%	705
2021 Q1	$2.34K	Hold	24	–	–	﹤0.01%	696
2020 Q4	$2.35K	Hold	24	–	–	﹤0.01%	697
2020 Q3	$2.58K	Sell	24 -247	-91%	-$27.5K	﹤0.01%	695
2020 Q2	$28.6K	Sell	271 -1	-0.4%	-$103	﹤0.01%	496
2020 Q1	$24.3K	Hold	272	–	–	﹤0.01%	527
2019 Q4	$27.1K	Buy	+272	New	+$25.6K	﹤0.01%	548

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Caldwell Trust's AZN Position: Q1 2026 in Review

Caldwell Trust increased its AstraZeneca (AZN) stake by 20% in Q1 2026, buying an estimated $214K and bringing the position to 6,618 shares worth $1.31M. The position accounts for 0.12% of the portfolio, ranked #142.

Caldwell Trust first reported a position in AZN in Q4 2019 and has held it in 20 quarters since. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Caldwell Trust held 6,618 shares of AstraZeneca worth $1.31M as of Q1 2026.
Caldwell Trust bought 1,108 AstraZeneca shares in Q1 2026, an estimated $214K.
AstraZeneca made up 0.12% of Caldwell Trust's portfolio in Q1 2026, its #142 holding.
Caldwell Trust first reported a position in AstraZeneca in Q4 2019 and has held it in 20 quarters since.
1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Caldwell Trust's 13F filing for Q1 2026, filed 22 Apr 2026.